Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-

/PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of...

Related Keywords

Pangyo , Kyonggi Do , South Korea , Janssen Pharma , Seungyong Yoon , Kyung Hoon Hwang , Taeyoung Yoon , University Of Ulsan College Medicine , Yuhan Corp , Asan Medical Center , Prnewswire Oscotec Inc , Oscotec Inc , Mild Cognitive Impairment , Clinical Investigation , Ulsan College , Hoon Hwang , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Biotechnology , Clinical Trials Amp Medical Discoveries ,